We are live on
!
Find out more
PM
Pembroke Management Portfolio holdings
AUM
$774M
1-Year Est. Return
40.73%
This Fund
S&P 500
This Quarter
Est. Return
+21.23%
1 Year Est. Return
+40.73%
3 Year Est. Return
+94.47%
5 Year Est. Return
+109.57%
10 Year Est. Return
+778.41%
AUM
$774M
AUM Growth
+$82.3M
(+12%)
Cap. Flow
-$24.7M
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
42.82%
Holding
112
New
15
Increased
22
Reduced
59
Closed
12
Avg Time Held
7.8
quarters
Top 10 Avg Time Held
2.9
quarters
Top 20 Avg Time Held
6.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VSE Corp
VSEC
|
+$19.2M |
| 2 |
Ollie's Bargain Outlet
OLLI
|
+$15.6M |
| 3 |
Ligand Pharmaceuticals
LGND
|
+$9.49M |
| 4 |
Timken Company
TKR
|
+$8.93M |
| 5 |
Saia
SAIA
|
+$5.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$19.5M |
| 2 |
MDA Space Ltd
MDA
|
+$16.9M |
| 3 |
Aaon
AAON
|
+$15.6M |
| 4 |
Workiva
WK
|
+$13.4M |
| 5 |
Core & Main
CNM
|
+$13.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 37.18% |
| 2 | Technology | 17.33% |
| 3 | Consumer Discretionary | 14.77% |
| 4 | Financials | 10.07% |
| 5 | Healthcare | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
26
Timken Company
TKR
$7.98B
| $10.8M | 1.39% |
+74,257
| New | +$8.93M |
2026 Q2
0 quarters
|
|
27
Boyd Group Services
BGSI
$2.18B
| $10.6M | 1.37% |
111,721
-2,348
| -2% | -$258K |
2025 Q4
2 quarters
|
|
28
Red Violet
RDVT
$1.29B
| $8.46M | 1.09% |
132,781
-656
| -0.5% | -$31K |
2024 Q3
7 quarters
|
|
29
Dutch Bros
BROS
$5.14B
| $8.24M | 1.07% |
114,750
+60,773
| +113% | +$3.49M |
2025 Q4
2 quarters
|
|
30
Obsidian Energy
OBE
$749M
| $8.05M | 1.04% |
990,264
+350,847
| +55% | +$3.94M |
2026 Q1
1 quarter
|
|
31
Cellebrite
CLBT
$2.88B
| $7.4M | 0.96% |
506,737
-131,212
| -21% | -$1.73M |
2024 Q1
9 quarters
|
|
32
Descartes Systems
DSGX
$7.16B
| $7.2M | 0.93% |
103,981
+658
| +0.6% | +$47K |
2014 Q4
46 quarters
|
|
33
Victory Capital Holdings
VCTR
$6.82B
| $6.78M | 0.88% |
80,712
-1,981
| -2% | -$159K |
2024 Q2
8 quarters
|
|
34
Gildan
GIL
$7.81B
| $6.37M | 0.82% |
123,397
-761
| -0.6% | -$43.7K |
2024 Q2
8 quarters
|
|
35
Porch Group
PRCH
$2.01B
| $6.19M | 0.8% |
411,859
+140,755
| +52% | +$1.39M |
2026 Q1
1 quarter
|
|
36
CRA International
CRAI
$1.12B
| $6.09M | 0.79% |
42,787
+691
| +2% | +$104K |
2018 Q4
30 quarters
|
|
37
Universal Technical Institute
UTI
$1.15B
| $5.9M | 0.76% |
137,993
-24,860
| -15% | -$955K |
2022 Q2
16 quarters
|
|
38
Pennant Group
PNTG
$1.42B
| $5.15M | 0.67% |
139,423
-4,594
| -3% | -$150K |
2026 Q1
1 quarter
|
|
39
iShares Core MSCI EAFE ETF
IEFA
$189B
| $4.95M | 0.64% |
51,225
-2,237
| -4% | -$215K |
2019 Q2
28 quarters
|
|
40
Ouster
OUST
$2.69B
| $4.92M | 0.64% |
+78,740
| New | +$2.65M |
2026 Q2
0 quarters
|
|
41
AAR Corp
AIR
$4.04B
| $4.71M | 0.61% |
32,984
-716
| -2% | -$84.5K |
2026 Q1
1 quarter
|
|
42
Telesat
TSAT
$688M
| $4.64M | 0.6% |
91,739
-1,090
| -1% | -$52.7K |
2026 Q1
1 quarter
|
|
43
Wingstop
WING
$3.43B
| $4.55M | 0.59% |
+26,229
| New | +$4.13M |
2026 Q2
0 quarters
|
|
44
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
| $3.99M | 0.52% |
48,213
-7,248
| -13% | -$578K |
2022 Q4
14 quarters
|
|
45
Bobs Discount Furniture
BOBS
$1.86B
| $3.94M | 0.51% |
248,792
+73,539
| +42% | +$913K |
2026 Q1
1 quarter
|
|
46
Main Street Capital
MAIN
$5.02B
| $3.44M | 0.44% |
66,279
+1,342
| +2% | +$70.7K |
2024 Q1
9 quarters
|
|
47
Life Time Group Holdings
LTH
$9.02B
| $3.39M | 0.44% |
+82,959
| New | +$2.63M |
2026 Q2
0 quarters
|
|
48
Five Below
FIVE
$11.8B
| $3.27M | 0.42% |
18,194
-548
| -3% | -$118K |
2025 Q3
3 quarters
|
|
49
Versigent PLC
VGNT
$3.08B
| $3.27M | 0.42% |
+77,842
| New | +$3.1M |
2026 Q2
0 quarters
|
|
50
10x Genomics
TXG
$9.8B
| $3.17M | 0.41% |
+82,793
| New | +$2.17M |
2026 Q2
0 quarters
|
|
Similar funds
CIA
CL
HI
GCM
CI
AF
HI
TCA
Pembroke Management's Q2 2026 Portfolio in Review
As of Q2 2026, Pembroke Management held 112 positions worth $774M, up 12% from $691M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Pembroke Management withdrew a net $24.7M in Q2 2026, closing 12 positions and reducing 59 holdings. Its most notable exit was Bio-Techne, an estimated $19.5M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 37% of assets, down from 38% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Pembroke Management opened a new position in Ligand Pharmaceuticals worth $12.7M.
- Pembroke Management's largest Q2 2026 buy was Ligand Pharmaceuticals: 40,277 shares worth $12.7M.
- Pembroke Management added most to VSE Corp in Q2 2026, an estimated $19.2M increase.
- Pembroke Management's biggest Q2 2026 reduction was MDA Space Ltd, cutting an estimated $16.9M.
- Pembroke Management fully exited Bio-Techne in Q2 2026, selling an estimated $19.5M.
- Pembroke Management's ten largest holdings make up 43% of its $774M portfolio in Q2 2026.
- Pembroke Management opened 15 new positions and closed 12 in Q2 2026.
- Pembroke Management's portfolio value rose 12% quarter-over-quarter to $774M.
Based on Pembroke Management's 13F filing for Q2 2026, filed 22 Jul 2026.